Abstract
Experimental studies to test the latest cytokine (or antibodies to it) in models of glomerular injury appear on an almost industrial scale. Most show modest benefits without providing serious mechanistic insights or the confidence that they will ever become clinical therapies. The article by
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
